Literature DB >> 15514977

Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.

Jessica J Hawes1, Marina R Picciotto.   

Abstract

The distribution of immunoreactivity for the three identified neuropeptide galanin receptors, GalR1, GalR2, and GalR3, was determined in areas of the mouse brain involved in drug addiction, including the ventral tegmental area (VTA), substantia nigra (SN), nucleus accumbens (NA), and locus coeruleus (LC). All three galanin receptors are found in the VTA, SN, NA, and LC; however, GalR1 protein is most highly represented in the VTA, NA, and SN, suggesting that GalR1 may play a predominant role in galanin-mediated regulation of dopamine neurotransmission. GalR1 and GalR3 protein levels are high in the LC, suggesting that these isoforms may be important for galanin-mediated regulation of noradrenergic transmission during opiate withdrawal. Although the distribution of GalR1, GalR2, and GalR3 largely recapitulates the pattern of galanin binding throughout the brain, some discrepancies exist, suggesting that another galanin receptor(s) may be present in some brain areas. Overall, GalR1, GalR2, and GalR3 are distributed widely throughout the brain, correlate with widespread galanin binding, and colocalize with tyrosine hydroxylase in catecholaminergic brain areas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15514977     DOI: 10.1002/cne.20329

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  26 in total

Review 1.  Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.

Authors:  Natale R Sciolino; Philip V Holmes
Journal:  Neurosci Biobehav Rev       Date:  2012-07-05       Impact factor: 8.989

Review 2.  Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides.

Authors:  Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2007-03-30

Review 3.  Galanin: a potential role in mesolimbic dopamine-mediated instrumental behavior.

Authors:  John K Robinson; Ariel Brewer
Journal:  Neurosci Biobehav Rev       Date:  2008-06-03       Impact factor: 8.989

Review 4.  Analysis of the network of feeding neuroregulators using the Allen Brain Atlas.

Authors:  Pawel K Olszewski; Jonathan Cedernaes; Fredrik Olsson; Allen S Levine; Helgi B Schiöth
Journal:  Neurosci Biobehav Rev       Date:  2008-03-29       Impact factor: 8.989

5.  Galanin protects against behavioral and neurochemical correlates of opiate reward.

Authors:  Jessica J Hawes; Darlene H Brunzell; Roopashree Narasimhaiah; Ulo Langel; David Wynick; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

6.  Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1.

Authors:  K Mitsukawa; X Lu; T Bartfai
Journal:  Neuroscience       Date:  2009-03-09       Impact factor: 3.590

Review 7.  Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.

Authors:  Marina R Picciotto; Christian Brabant; Emily B Einstein; Helen M Kamens; Nichole M Neugebauer
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

8.  Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects.

Authors:  Olga Karatayev; Jessica R Barson; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Peptides       Date:  2009-09-24       Impact factor: 3.750

9.  Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice.

Authors:  Roopashree Narasimhaiah; Helen M Kamens; Marina R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

10.  The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex.

Authors:  Yvonne E Ogbonmwan; Natale R Sciolino; Jessica L Groves-Chapman; Kimberly G Freeman; Jason P Schroeder; Gaylen L Edwards; Philip V Holmes; David Weinshenker
Journal:  Addict Biol       Date:  2014-07-23       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.